跳至主要内容
临床试验/NCT04256746
NCT04256746已完成不适用

A Natural Extract for Reducing the Post Prandial Blood Glucose Response in Healthy Indian Adults: A Dose-response Study of Efficacy and Tolerance

Unilever R&D2 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2012年9月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84
试验地点
2
主要终点
Post-prandial blood glucose

研究概览

简要总结

Randomized, balanced incomplete block design dose response study of efficacy, with 4 different dosages of mulberry fruit powdered extract added to cooked rice compared to a reference treatment (cooked rice only).

详细描述

Dose response study with 4 dosages of mulberry fruit powdered extract (0.37, 0.75, 1.12 and 1.5 g) added to cooked rice, compared to cooked rice only(reference) on post prandial blood glucose response in healthy Indian adults.

In addition, 1.5 g of mulberry fruit powdered extract was added to instant rice porridge and compared to instant rice porridge only as positive control (replication of previous research.

In total there were 7 test products in the study: 5 active treatments and 2 reference treatments.

The study was a cross-over study (4 interventions per subject, 4 out of the 7 test products). The recovery period between treatments was at least seven days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The coded and un-coded randomization schedule was generated by the bio-statistician of CRO.

The person involved in the preparation of the test product was not involved in any other activities related to the study.

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Willing to give consent to participate in the study in writing;
  • Healthy male and female subjects between ≥ 20 and ≤ 50.0 years of age;
  • BMI of ≥18.0 and ≤ 25.0 kg/m2;
  • Apparently healthy: no medical conditions which might effect study measurements as judged by the study physician or measured by questionnaire, and/or assessed by hematology, blood chemistry and urinalysis;
  • Willing to comply to study protocol during the study;
  • Agreeing to be informed about medically relevant personal test-results by study physician;
  • Willing to refrain from drinking of alcohol on and one day before the blood withdrawal;
  • Fasting blood glucose value of volunteer is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening;
  • Haemoglobin level within clinically acceptable range (for male 12 to 17 gm/dL and for females 11 to 15 gm / dL; both inclusive) as judged by the research physician.

排除标准

  • Being an employee of Unilever of Lambda;
  • Chronic smokers, tobacco chewers and drinkers;
  • Participation in any other biomedical study 3 months before screening visit day of this study and/or participating in any other biomedical study during the screening period;
  • High intake of alcohol (>120 mL/week);
  • Reported use of medically prescribed/slimming diet;
  • Reported participation in night shifts (between 23.00 and 6.00 hrs);
  • Use of medication which interferes with study measurements including vitamins, tonics;
  • Reported intense exercise ≥10 h/week;
  • Reported weight loss/gain ≥ 10% of body weight in the 6 months preceding screening
  • Blood donation for 2 months prior to screening;
  • Urine analysis that showed any drug abuse;
  • Allergy to any food or cosmetics;
  • If female, not being pregnant or planning pregnancy during the study period;
  • If female, lactating or has been lactating for 6 weeks before pre-study investigation and/or during the study period.

结局指标

主要结局

Post-prandial blood glucose

时间窗: Positive incremental Area under the glucose versus time Curve between 0 (before) and 2 hours after test product intake

Glucose concentration in venous plasma

次要结局

  • Post-prandial insulin(Total area under the insulin versus time curves between 0 (before) and 2 hours after study product intake)

研究者

发起方
Unilever R&D
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验